BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

Sep 25 2018
Legislation will strengthen pipeline of medical countermeasures against serious public health threats   Washington, DC (September 25, 2018) – The Biotechnology Innovation Organization (BIO) today applauds the House of Representatives for passing the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (H.R. 6378). The legislation would re-authorize critical federal biodefense programs and agencies, including the BioShield Special Reserve Fund (SRF), the Biomedical Advanced Research and Development Authority (BARDA), and the Strategic National Stockpile (SNS).  

BIO Applauds Release of New National Biodefense Strategy

Sep 19 2018
“I applaud the Administration for recognizing the importance of strengthening our national biodefense and preparedness efforts. Our nation continues to face a wide range of biological threats, and this strategy is an important step in the right direction."

BIO Applauds Senate Passage of Opioid Crisis Response Act of 2018

Sep 17 2018
“BIO’s member companies are committed to unleashing the power of scientific innovation to develop solutions that will lead to an America free of prescription opioid addiction. Today’s vote advances vital legislation that will help get new innovations to patients suffering from pain and addiction, by ensuring that our research and regulatory environments keep pace with our accelerating scientific knowledge and capabilities."

BIO Applauds Legislation to Spur Investment in Start-ups

Sep 12 2018
Washington, DC (September 12, 2018) – The Biotechnology Innovation Organization (BIO) today applauded the introduction of the American Innovation Act of 2018 (H.R. 6756), which includes a provision that would protect investments in start-ups from inadvertently triggering the net operating loss (NOL) limitations under Section 382 of the tax code. R&D-intensive biotech start-ups frequently accumulate substantial NOLs in their early, pre-revenue years, given their typical reliance on investor capital for more than a decade before realizing any product revenue.

BIO Announces Programming for the 17th Annual BIO Investor Forum

Sep 4 2018
Amidst a healthy investment climate for biotech companies, BIO announces programming for the 17th annual BIO Investor Forum

BIO Urges EPA to Help Boost America’s Rural Economy

Aug 20 2018
On Friday, August 17, the Biotechnology Innovation Organization (BIO) urged the Environmental Protection Agency (EPA) to use its authority under the Renewable Fuel Standard (RFS) program to strengthen America’s biobased economy.

BIO Releases Statement on NGA’s Report on Prescription Drug Costs

Aug 10 2018
Washington, DC (August 10, 2018) – Tom Dilenge, president of advocacy, law & public policy at the Biotechnology Innovation Organization (BIO), issued the following statement today after the National Governors Association (NGA) released a report outlining “potential state strategies” to address prescription drug costs...

Congressman Tom Suozzi to Spotlight Scientific and Economic Development Advancements in New York

Jul 27 2018
Congressman Tom Suozzi will join leaders of New York’s biotechnology community for a tour of Alexandria LaunchLabs on Monday, July 30, 2018 at 11:00 am.

BIO Wraps Up Transformative 2018 BIO World Congress in Philadelphia

Jul 19 2018
Philadelphia (July 19, 2018) – The 15th annual BIO World Congress on Industrial Biotechnology concluded today at the Pennsylvania Convention Center in Philadelphia. The BIO World Congress continues to be the largest industrial biotechnology conference in the world, and this year’s event had a significant international presence with 44 percent of attendees coming from outside the United States. Additionally, more than 100 new companies were in attendance in Philadelphia.

BIO Announces Dr. Larry Walker as the Leadership and Legacy Award Recipient at the 2018 BIO World Congress

Jul 19 2018
Philadelphia (July 19, 2018) –The Biotechnology Innovation Organization (BIO) today presented Dr. Larry Walker, co-editor in chief for the journal “Industrial Biotechnology,” with the third annual BIO Leadership and Legacy Award in Industrial Biotechnology and Agriculture. The award presentation took place during a lunch plenary session at the 2018 BIO World Congress on Industrial Biotechnology. The world’s largest industrial biotechnology and partnering event was held July 16-19, 2018 at the Pennsylvania Convention Center in Philadelphia.